FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy

The additional indication for the preparation kit of gallium Ga-68 gozetotide may facilitate earlier use of PSMA-targeted treatment for men with prostate cancer.

Read the full article on diagnosticimaging.com